On this page:OverviewKey papers
ScholarIQanswers from OpenAlex

Drugs in R&D

JournalCitation impact & published research

Drugs in R&D is a journal indexed in ScholarIQ from OpenAlex.

What is the OpenAlex record for Drugs in R&D?

ScholarIQopenalex

The OpenAlex for Drugs in R&D is on the source record.

What are the most-cited papers on Drugs in R&D?

ScholarIQmost cited works
The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing–Remitting and Secondary Progressive Multiple Sclerosis
Martin Vališ, Anat Achiron, Hans Hartung, Jan Mareš, Veronika Tichá, Pavel Štourač, Simona Halúsková, Francesco Angelucci, Zbyšek Pavelek
Drugs in R&D. 202318 CitationsOPEN ACCESS
Analysis of the US Safety Data for Edaravone (Radicava®) From the Third Year After Launch
Angela Genge, Benjamin Rix Brooks, Björn Oskarsson, Alexander Kalin, Ming Ji, Stephen Apple, Laura Bower
Drugs in R&D. 202217 CitationsOPEN ACCESS
Safety of Mebendazole Use During Lactation: A Case Series Report
Nour Karra, Rana Cohen, Maya Berlin, Natalie Dinavitser, Gideon Koren, Matitiahu Berkovitch
Drugs in R&D. 201610 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial